The new drug could provide relief for around 1,000 women in England, but 1.5 million in the UK suffer with the condition ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

The UK's NHS has approved a first daily pill, relugolix combination therapy, to treat endometriosis symptoms. The new ...

"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Of the 1.5 million women in the UK currently suffering from endometriosis, around 1,000 women are estimated to receive the ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The drug, also called Relugolix, blocks signals from the brain that tell the ovaries to make oestrogen, a hormone that fuels ...

The National Institute for Health and Care Excellence (NICE) has recommended Gideon Richter’s Ryeqo (relugolix, estradiol and ...

While, on average, it takes eight years to be diagnosed with endometriosis, there are, thankfully, new breakthroughs in ...